Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Cornerstone Industries International Inc. (Tier2) (CIA)

Cornerstone Industries International Inc. (Tier2)
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:CIA
DateTimeSourceHeadlineSymbolCompany
19/10/201002:43Marketwired CanadaProMetic Signs Terms of Strategic Agreement for PBI-1402 and PBI-4419 With Allist Pharmaceuticals of ChinaTSXV:CIACornerstone Industries International Inc. (Tier2)
23/10/200917:00Marketwired CanadaProMetic to Report Results of PBI-1402 Data at Upcoming Annual Meeting of American Society of NephrologyTSXV:CIACornerstone Industries International Inc. (Tier2)
14/06/200817:00Marketwired CanadaPositive Clinical Data for PBI-1402 Presented at the Annual Congress of the European Hematology AssociationTSXV:CIACornerstone Industries International Inc. (Tier2)
15/05/200822:30Marketwired CanadaProMetic Reports Business Highlights and First Quarter Financial ResultsTSXV:CIACornerstone Industries International Inc. (Tier2)
23/04/200812:00Marketwired CanadaProMetic Life Sciences Inc.: Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical TrTSXV:CIACornerstone Industries International Inc. (Tier2)
28/03/200821:18Marketwired CanadaProMetic Announce Highlights and Year End Financials for 2007TSXV:CIACornerstone Industries International Inc. (Tier2)
12/09/200711:00Marketwired CanadaProMetic Expands Indication for PBI-1402 Into Anemia In Cancer PatientsTSXV:CIACornerstone Industries International Inc. (Tier2)
 Showing the most relevant articles for your search:TSXV:CIA

Your Recent History

Delayed Upgrade Clock